elastase inhibitors containing conformationally restricted lactams as P3-P2 dipeptide replacements
- 30 April 1993
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 3 (4) , 773-778
- https://doi.org/10.1016/s0960-894x(01)81273-7
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- On the size of the active site in proteases. I. PapainPublished by Elsevier ,2005
- Inhibition of human leukocyte elastase by N-substituted peptides containing .alpha.,.alpha.-difluorostatone residues at P1Journal of Medicinal Chemistry, 1992
- Inhibition of human leukocyte elastase (HLE) by N-substituted peptidyl trifluoromethyl ketonesJournal of Medicinal Chemistry, 1992
- A versatile synthesis of peptidyl fluoromethyl ketonesTetrahedron Letters, 1986
- Angiotensin converting enzyme inhibitors: 1,5-benzothiazepine derivativesJournal of Medicinal Chemistry, 1985
- Bicyclic lactam inhibitors of angiotensin converting enzymeJournal of Medicinal Chemistry, 1984
- Interactions of Granulocyte Proteases with Inhibitors in Rheumatoid ArthritisPublished by Springer Nature ,1984
- The design and synthesis of new triazolo, pyrazolo-, and pyridazo-pyridazine derivatives as inhibitors of angiotensin converting enzymeJournal of the Chemical Society, Perkin Transactions 1, 1984
- Dipeptide mimics. Conformationally restricted inhibitors of angiotensin-converting enzymeBiochemical and Biophysical Research Communications, 1983
- An Improved Synthesis of γ-, δ-, and ε-LactamsSynthesis, 1978